|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-12
|
|
pubmed:abstractText |
To assess virological efficacy of a ritonavir-boosted atazanavir (ATV/r)-containing regimen in patients with persistent viral replication despite HAART.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-51
|
|
pubmed:meshHeading |
pubmed-meshheading:18547901-Adult,
pubmed-meshheading:18547901-Anti-HIV Agents,
pubmed-meshheading:18547901-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18547901-Cohort Studies,
pubmed-meshheading:18547901-Drug Administration Schedule,
pubmed-meshheading:18547901-Female,
pubmed-meshheading:18547901-France,
pubmed-meshheading:18547901-HIV Infections,
pubmed-meshheading:18547901-Humans,
pubmed-meshheading:18547901-Male,
pubmed-meshheading:18547901-Middle Aged,
pubmed-meshheading:18547901-Oligopeptides,
pubmed-meshheading:18547901-Pyridines,
pubmed-meshheading:18547901-Ritonavir,
pubmed-meshheading:18547901-Treatment Failure,
pubmed-meshheading:18547901-Virus Replication
|
|
pubmed:articleTitle |
Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohort.
|
|
pubmed:affiliation |
CISIH-Hôpital Purpan, Toulouse, France. Cuzin.l@chu-toulouse.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
